All In MedTech

Device Trial Radar · NCT07135596

Effectiveness and Safety of OviTex® PRS in Breast Reconstruction

Research on the Effectiveness and Safety of Treatment With OviTex® PRS - a Breast Reconstruction Evaluation

Last checked: Nov 19, 2026Latest source record: Sep 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

235

Planned (sponsor's estimate)

Start

Apr 10, 2026

Primary completion

Jun 2030

Study completion Jun 2034

Sponsor

Lead sponsor
Tela Bio IncNot on our public-company list
Sponsor type
Industry
First posted
Aug 22, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
Female only, from 22 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety and effectiveness of OviTex PRS in subjects undergoing implant-based breast reconstruction.

Conditions

  • Breast Reconstruction

Interventions

  • OviTex PRSDevice

    A multi-layer construct of extracellular matrix (ECM) derived from ovine forestomach and embroidered with polymer filament.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Reconstructive Failure RateTime frame: From enrollment to 12 months
  2. Major Complication RateTime frame: From enrollment to 12 months

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • University of South Florida Plastic Surgery

    Tampa, Florida · Recruiting

  • Qualmedica Research

    Bowling Green, Kentucky · Recruiting

  • WakeMed

    Raleigh, North Carolina · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.